Search

Displaying results 3591 - 3600 of 5925 in total
  1. Drug

    Zilantel

    go.drugbank.com/drugs/DB20793
    Experimental

    Zilantel has a monoisotopic molecular weight of 664.11 Da.

  2. Drug

    Haloprogesterone

    go.drugbank.com/drugs/DB20259
    Experimental

    Haloprogesterone has a monoisotopic molecular weight of 410.13 Da.

  3. Drug

    Bleselumab

    go.drugbank.com/drugs/DB15253
    Investigational

    Bleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney

  4. Drug

    Belfosdil

    go.drugbank.com/drugs/DB21327
    Experimental

    Belfosdil has a monoisotopic molecular weight of 548.3 Da.

  5. Drug

    Litomeglovir

    go.drugbank.com/drugs/DB21363
    Experimental

    Litomeglovir has a monoisotopic molecular weight of 498.19 Da.

  6. Drug

    Norgesterone

    go.drugbank.com/drugs/DB21409
    Experimental

    Norgesterone has a monoisotopic molecular weight of 300.21 Da.

  7. Drug

    Pitenodil

    go.drugbank.com/drugs/DB21442
    Experimental

    Pitenodil has a monoisotopic molecular weight of 353.18 Da.

  8. Drug

    Iodocetylic acid I-123

    go.drugbank.com/drugs/DB19593
    Experimental

    Iodocetylic acid I-123 has a monoisotopic molecular weight of 378.14 Da.

  9. Drug

    Gliclazide

    go.drugbank.com/drugs/DB01120
    ApprovedInvestigational

    Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. … It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesSynonyms: 1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
  10. Drug

    Bromopride

    go.drugbank.com/drugs/DB09018
    Investigational

    Bromopride is a dopamine antagonist used as an antiemetic. Its prokinetic properties are similar to those of metoclopramide. It is unavailable in America or the United Kingdom.

    Categories: Dopamine D2 Receptor Antagonists